Follow-The-Filings

Security · featured owners

NUVB Nuvation Bio Inc.

Health Care COM CL A Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 0.5%
  • $35M
  • 1 reduce 1 exit

NUVB (Nuvation Bio Inc.) is held in 4 featured 13F books as of 2026 Q2. Stanley Druckenmiller - Duquesne Family Office is the largest tracked holder by portfolio weight (0.49%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.5% (Stanley Druckenmiller - Duquesne Family Office) · not free-float ownership

  1. Stanley Druckenmiller 0.49%
  2. Palo Alto Investors Reduce 0.26%
  3. David Abrams 0.13%
  4. David Einhorn 0.01%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.49% Hold 4,539,800 $26M History
David Abrams - Abrams Capital Management 2026 Q2 0.13% Hold 1,270,504 $7M History
Palo Alto Investors 2026 Q2 0.26% Reduce −35.8% 326,609 $2M History
David Einhorn - DME Capital Management 2026 Q2 0.01% Hold 34,995 $199K History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 29,000 $124K History

4 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.03,8.01,9.01 Filing Doc
8-K 1.01,1.02,2.03,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 1.01,2.02,7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Aug 19, 2026 Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jun 23, 2026 · 3 forms Filing Doc
4 Period Jun 9, 2026 Filing Doc
4/A Period Feb 27, 2026 Filing Doc
4 Period May 21, 2026 · 6 forms Filing Doc
4 Period Apr 17, 2026 · 2 forms Filing Doc
4 Period Apr 6, 2026 Filing Doc
4 Period Feb 27, 2026 · 9 forms Filing Doc

Updated 21 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $7.87M $62.9M
Gross profit — $795,000 —
Gross margin * — 10.1% —
Net income -$75.8M -$567.94M -$204.63M
Net margin * — -7213.8% -325.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $616.43M $526.26M $571.52M
Total non-current assets * $5.05M $14.37M $23.3M
Total assets $621.48M $540.63M $594.82M
Total current liabilities $13.97M $58.24M $82.23M
Total non-current liabilities * $2.39M $18.59M $206.88M
Total equity $605.12M $463.79M $305.72M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$68M -$130.41M -$173.43M
Cash from investing $8.92M $122.7M $99.52M
Cash from financing $0.628M $0.331M $202.54M
Net change in cash -$58.45M -$6.93M $128.36M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders